Literature DB >> 8258725

A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders.

I C Le Poole1, T Mutis, R M van den Wijngaard, W Westerhof, T Ottenhoff, R R de Vries, P K Das.   

Abstract

It is now well established that cultured human melanocytes are capable of expressing immunologically important cell surface molecules and that they can produce cytokines. Not all cells with the ability to express MHC class II molecules are capable of effective Ag presentation. However, the dendritic nature of melanocytes, their strategic position within the skin, and their phagocytic capacity seem to suggest a role for these cells in processing and presenting Ag. This study demonstrates that cultured normal human skin melanocytes can present peptide Ag, and process and present the mycobacterial HSP65 kDa protein and whole Mycobacterium leprae sonicate to CD4+ cytotoxic proliferative T cell clones in an Ag-specific and HLA-class II-restricted manner. T cell stimulation was dependent on costimulatory signals, i.e., LFA-3/CD2 and LFA-1/ICAM-1. Besides eliciting a T cell proliferative response, our studies further demonstrate that melanocytes can function as target cells for T cell-mediated cytotoxicity. The described Ag-processing and -presenting functions of melanocytes, taken together with in vivo behavior of melanocytes in hypopigmentation, provide new clues for the etiopathogenesis of melanin pigmentary disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258725

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis.

Authors:  J Chesney; R Bucala
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

2.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.

Authors:  Jeffrey A Mosenson; Kelsey Flood; Jared Klarquist; Jonathan M Eby; Amy Koshoffer; Raymond E Boissy; Andreas Overbeck; Rebecca C Tung; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-01-13       Impact factor: 4.693

Review 4.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

Review 5.  Therapeutic implications of autoimmune vitiligo T cells.

Authors:  Kepa Oyarbide-Valencia; Jasper G van den Boorn; Cecele J Denman; Mingli Li; Jeremy M Carlson; Claudia Hernandez; Michael I Nishimura; Pranab K Das; Rosalie M Luiten; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2006-05-06       Impact factor: 9.754

6.  Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes.

Authors:  I C Le Poole; F M van den Berg; R M van den Wijngaard; D A Galloway; P J van Amstel; A A Buffing; H L Smits; W Westerhof; P K Das
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-01       Impact factor: 2.416

7.  GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.

Authors:  Matthew P Rausch; Kari R Irvine; Paul A Antony; Nicholas P Restifo; Peter Cresswell; K Taraszka Hastings
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

8.  Extracellular and intracellular melanin in inflammatory middle ear disease.

Authors:  Mark A Fritz; Pamela C Roehm; Michael A Bannan; Anil K Lalwani
Journal:  Laryngoscope       Date:  2014-06       Impact factor: 3.325

Review 9.  New perspectives on the role of vitiligo in immune responses to melanoma.

Authors:  Katelyn T Byrne; Mary Jo Turk
Journal:  Oncotarget       Date:  2011-09

10.  T-cell reconstitution after thymus xenotransplantation induces hair depigmentation and loss.

Authors:  Anna L Furmanski; Ryan F L O'Shaughnessy; Jose Ignacio Saldana; Michael P Blundell; Adrian J Thrasher; Neil J Sebire; E Graham Davies; Tessa Crompton
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.